Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for upper eyelid retraction in thyroid eye disease
NCT04359979Unknown
- Sponsor
- Sheba Medical Center
- Start
- May 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamsulosin in thyroid eye disease (TED), sponsored by Sheba Medical Center. Primary endpoint: eyelid retraction at 3 months. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT04359979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04359979.